{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T04:36:23Z","timestamp":1785558983589,"version":"3.56.0"},"reference-count":106,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["32333"],"award-info":[{"award-number":["32333"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.beem.2018.09.004","type":"journal-article","created":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T12:37:45Z","timestamp":1537619865000},"page":"593-607","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":104,"title":["Primary hyperparathyroidism"],"prefix":"10.1016","volume":"32","author":[{"given":"Barbara C.","family":"Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie E.","family":"Cusano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Bilezikian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2018.09.004_bib1","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0140-6736(17)31430-7","article-title":"Hyperparathyroidism","volume":"391","author":"Bilezikian","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2018.09.004_bib2","doi-asserted-by":"crossref","first-page":"16033","DOI":"10.1038\/nrdp.2016.33","article-title":"Primary hyperparathyroidism","volume":"2","author":"Bilezikian","year":"2016","journal-title":"Nat Rev Dis Prim"},{"key":"10.1016\/j.beem.2018.09.004_bib3","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1210\/jc.2014-1414","article-title":"Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop","volume":"99","author":"Eastell","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2018.09.004_bib4","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s00268-016-3716-6","article-title":"Use of calcium and parathyroid hormone nomogram to distinguish between atypical primary hyperparathyroidism and normal patients","volume":"41","author":"Lavryk","year":"2017","journal-title":"World J Surg"},{"key":"10.1016\/j.beem.2018.09.004_bib5","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1007\/s00268-017-3888-8","article-title":"Primary hyperparathyroidism with normal calcium and PTH","volume":"41","author":"Rosario","year":"2017","journal-title":"World J Surg"},{"key":"10.1016\/j.beem.2018.09.004_bib6","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1210\/jc.2014-2000","article-title":"The surgical management of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop","volume":"99","author":"Udelsman","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2018.09.004_bib7","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1210\/jc.2014-1413","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop","volume":"99","author":"Bilezikian","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2018.09.004_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00198-016-3716-2","article-title":"Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and International consensus","volume":"28","author":"Khan","year":"2017","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.beem.2018.09.004_bib9","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1001\/jamasurg.2017.1721","article-title":"Indications for surgical management of hyperparathyroidism: a review","volume":"152","author":"Stephen","year":"2017","journal-title":"JAMA Surg"},{"key":"10.1016\/j.beem.2018.09.004_bib10","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/jamasurg.2016.2310","article-title":"The American association of endocrine surgeons guidelines for definitive management of primary hyperparathyroidism","volume":"151","author":"Wilhelm","year":"2016","journal-title":"JAMA Surg"},{"key":"10.1016\/j.beem.2018.09.004_bib11","series-title":"The parathyroids","first-page":"297","article-title":"Epidemiology of primary hyperparathyroidism","author":"Wermers","year":"2015"},{"key":"10.1016\/j.beem.2018.09.004_bib12","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.surg.2013.06.051","article-title":"The prevalence of undiagnosed and unrecognized primary hyperparathyroidism: a population-based analysis from the electronic medical record","volume":"154","author":"Press","year":"2013","journal-title":"Surgery"},{"key":"10.1016\/j.beem.2018.09.004_bib13","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1210\/jc.2012-4022","article-title":"Incidence and prevalence of primary hyperparathyroidism in a racially mixed population","volume":"98","author":"Yeh","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2018.09.004_bib14","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1210\/jc.2013-1300","article-title":"Normocalcemic hyperparathyroidism and hypoparathyroidism in two community-based nonreferral populations","volume":"98","author":"Cusano","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2018.09.004_bib15","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1530\/EC-15-0030","article-title":"Normocalcemic primary hyperparathyroidism: a survey in a small village of Southern Italy","volume":"4","author":"Vignali","year":"2015","journal-title":"Endocr Connect"},{"key":"10.1016\/j.beem.2018.09.004_bib16","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/cen.12819","article-title":"Normocalcaemic, vitamin D-sufficient hyperparathyroidism \u2013 high prevalence and low morbidity in the general population: a long-term follow-up study, the WHO MONICA project, Gothenburg, Sweden","volume":"83","author":"Kontogeorgos","year":"2015","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2018.09.004_bib17","first-page":"A4567","article-title":"Increasing incidence of primary hyperparathyroidism in Denmark","volume":"60","author":"Abood","year":"2013","journal-title":"Dan Med J"},{"issue":"Suppl. 2","key":"10.1016\/j.beem.2018.09.004_bib18","first-page":"N18","article-title":"Epidemiology of primary hyperparathyroidism in Europe","volume":"17","author":"Adami","year":"2002","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2018.09.004_bib19","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3109\/07435800.2016.1169545","article-title":"Primary hyperparathyroidism: increasing prevalence, social deprivation, and surgery","volume":"42","author":"Collier","year":"2017","journal-title":"Endocr Res"},{"issue":"3","key":"10.1016\/j.beem.2018.09.004_bib20","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s00198-017-4322-7","article-title":"Characteristics, management, and outcome of primary hyperparathyroidism at a single clinical center from 2005 to 2016","volume":"29","author":"Sun","year":"2018","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.beem.2018.09.004_bib21","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1210\/jc.2007-1215","article-title":"The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years","volume":"93","author":"Rubin","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2018.09.004_bib22","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1210\/jc.2006-2802","article-title":"Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype","volume":"92","author":"Lowe","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2018.09.004_bib23","doi-asserted-by":"crossref","first-page":"921814","DOI":"10.1155\/2011\/921814","article-title":"Systematic review of primary hyperparathyroidism in India: the past, present, and the future trends","volume":"2011","author":"Pradeep","year":"2011","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.beem.2018.09.004_bib24","doi-asserted-by":"crossref","first-page":"952426","DOI":"10.1155\/2012\/952426","article-title":"Primary hyperparathyroidism: 11-year experience in a single institute in Thailand","volume":"2012","author":"Prasarttong-Osoth","year":"2012","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.beem.2018.09.004_bib25","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4248\/BR201302005","article-title":"Primary hyperparathyroidism: a tale of two cities revisited \u2013 New York and Shanghai","volume":"1","author":"Liu","year":"2013","journal-title":"Bone Res"},{"key":"10.1016\/j.beem.2018.09.004_bib26","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1590\/S0004-27302006000400011","article-title":"From mild to severe primary hyperparathyroidism: the Brazilian experience","volume":"50","author":"Bandeira","year":"2006","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"10.1016\/j.beem.2018.09.004_bib27","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4137\/CMED.S13147","article-title":"Epidemiology of primary hyperparathyroidism and its non-classical manifestations in the city of Recife, Brazil","volume":"6","author":"Eufrazino","year":"2013","journal-title":"Clin Med Insights Endocrinol Diabetes"},{"key":"10.1016\/j.beem.2018.09.004_bib28","first-page":"408","article-title":"Primary hyperparathyroidism: postoperative long-term evolution","volume":"70","author":"Spivacow","year":"2010","journal-title":"Medicina (B Aires)"},{"key":"10.1016\/j.beem.2018.09.004_bib29","doi-asserted-by":"crossref","first-page":"4148","DOI":"10.1210\/jc.2017-01080","article-title":"Sex difference in the clinical presentation of primary hyperparathyroidism: influence of menopausal status","volume":"102","author":"Castellano","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2018.09.004_bib30","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1002\/cncr.22599","article-title":"Trends in the incidence and treatment of parathyroid cancer in the United States","volume":"109","author":"Lee","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.beem.2018.09.004_bib31","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/joim.12523","article-title":"Genetics of parathyroid tumours","volume":"280","author":"Thakker","year":"2016","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.beem.2018.09.004_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186485","article-title":"Mutational and large deletion study of genes implicated in hereditary forms of primary hyperparathyroidism and correlation with clinical features","volume":"12","author":"Pardi","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.beem.2018.09.004_bib33","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1002\/jbmr.3296","article-title":"Hypercalcemic disorders in children","volume":"32","author":"Stokes","year":"2017","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2018.09.004_bib34","doi-asserted-by":"crossref","first-page":"e6390","DOI":"10.1136\/bmj.e6390","article-title":"Calcium intake and risk of primary hyperparathyroidism in women: prospective cohort study","volume":"345","author":"Paik","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.beem.2018.09.004_bib35","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1210\/jc.2015-3836","article-title":"Physical activity and the risk of primary hyperparathyroidism","volume":"101","author":"Vaidya","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2018.09.004_bib36","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1002\/jbmr.3168","article-title":"Body size and the risk of primary hyperparathyroidism in women: a cohort study","volume":"32","author":"Vaidya","year":"2017","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2018.09.004_bib37","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1210\/jc.2015-1619","article-title":"Hypertension, antihypertensive medications, and risk of incident primary hyperparathyroidism","volume":"100","author":"Vaidya","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2018.09.004_bib38","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1056\/NEJMc1104982","article-title":"The parathyroid as a target for radiation damage","volume":"365","author":"Boehm","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2018.09.004_bib39","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1001\/jama.1990.03450050039024","article-title":"A\u00a0prospective study of hyperparathyroidism in individuals exposed to radiation in childhood","volume":"264","author":"Cohen","year":"1990","journal-title":"Jama"},{"key":"10.1016\/j.beem.2018.09.004_bib40","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1530\/EJE-08-0620","article-title":"Lithium-associated hyperparathyroidism: report of four cases and review of the literature","volume":"160","author":"Szalat","year":"2009","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.beem.2018.09.004_bib41","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1210\/jc.2015-3964","article-title":"Thiazide-associated hypercalcemia: incidence and association with primary hyperparathyroidism over two decades","volume":"101","author":"Griebeler","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2018.09.004_bib42","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.1210\/jc.2014-1415","article-title":"Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop","volume":"99","author":"Silverberg","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2018.09.004_bib43","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1210\/jc.2014-3708","article-title":"Prevalence of kidney stones and vertebral fractures in primary hyperparathyroidism using imaging technology","volume":"100","author":"Cipriani","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2018.09.004_bib44","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1590\/0004-2730000003381","article-title":"Bone disease in primary hyperparathyroidism","volume":"58","author":"Bandeira","year":"2014","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"10.1016\/j.beem.2018.09.004_bib45","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s12020-017-1414-2","article-title":"Osteitis fibrosa cystica-a forgotten radiological feature of primary hyperparathyroidism","volume":"58","author":"Misiorowski","year":"2017","journal-title":"Endocrine"},{"key":"10.1016\/j.beem.2018.09.004_bib46","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/jbmr.5650040302","article-title":"Skeletal disease in primary hyperparathyroidism","volume":"4","author":"Silverberg","year":"1989","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2018.09.004_bib47","series-title":"The parathyroids","first-page":"457","article-title":"Skeletal disease in primary hyperparathyroidism","author":"Bilezikian","year":"1994"},{"key":"10.1016\/j.beem.2018.09.004_bib48","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1359\/jbmr.1999.14.10.1700","article-title":"Primary hyperparathyroidism and the risk of fracture: a population-based study","volume":"14","author":"Khosla","year":"1999","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2018.09.004_bib49","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1210\/jc.2008-2006","article-title":"Morphometric vertebral fractures in postmenopausal women with primary hyperparathyroidism","volume":"94","author":"Vignali","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2018.09.004_bib50","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/jbmr.98","article-title":"Effects on bone geometry, density, and microarchitecture in the distal radius but not the tibia in women with primary hyperparathyroidism: a case-control study using HR-pQCT","volume":"25","author":"Hansen","year":"2010","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2018.09.004_bib51","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1210\/jc.2012-4255","article-title":"Trabecular bone score (TBS)\u2013a novel method to evaluate bone microarchitectural texture in patients with primary hyperparathyroidism","volume":"98","author":"Silva","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2018.09.004_bib52","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1002\/jbmr.1841","article-title":"Primary hyperparathyroidism is associated with abnormal cortical and trabecular microstructure and reduced bone stiffness in postmenopausal women","volume":"28","author":"Stein","year":"2013","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2018.09.004_bib53","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bone.2013.03.009","article-title":"New insights into the effects of primary hyperparathyroidism on the cortical and trabecular compartments of bone","volume":"55","author":"Vu","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.beem.2018.09.004_bib54","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0002-9343(89)80613-8","article-title":"Neuromuscular involvement in mild, asymptomatic primary hyperparathyroidism","volume":"87","author":"Turken","year":"1989","journal-title":"Am J Med"},{"key":"10.1016\/j.beem.2018.09.004_bib55","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1210\/jc.2007-0219","article-title":"Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial","volume":"92","author":"Ambrogini","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2018.09.004_bib56","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1210\/jc.2006-1836","article-title":"Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial","volume":"92","author":"Bollerslev","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2018.09.004_bib57","doi-asserted-by":"crossref","first-page":"5415","DOI":"10.1210\/jc.2004-0028","article-title":"Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism","volume":"89","author":"Rao","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2018.09.004_bib58","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1210\/jc.2008-2574","article-title":"Neuropsychological features in primary hyperparathyroidism: a prospective study","volume":"94","author":"Walker","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2018.09.004_bib59","series-title":"The parathyroids","first-page":"469","article-title":"Non-traditional manifestations of primary hyperparathyroidism","author":"Walker","year":"2015"},{"key":"10.1016\/j.beem.2018.09.004_bib60","series-title":"Endotext","article-title":"Primary hyperparathyroidism","author":"Bilezikian","year":"2000"},{"key":"10.1016\/j.beem.2018.09.004_bib61","first-page":"128352","article-title":"Normocalcemic versus hypercalcemic primary hyperparathyroidism: more stone than bone?","volume":"2012","author":"Amaral","year":"2012","journal-title":"J\u00a0Osteoporos"},{"key":"10.1016\/j.beem.2018.09.004_bib62","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1007\/s12020-012-9694-z","article-title":"Normocalcemic primary hyperparathyroidism: one-year follow-up in one hundred postmenopausal women","volume":"42","author":"Garcia-Martin","year":"2012","journal-title":"Endocrine"},{"key":"10.1016\/j.beem.2018.09.004_bib63","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1590\/S0004-27302011000500003","article-title":"Normocalcemic primary hyperparathyroidism in clinical practice: an indolent condition or a silent threat?","volume":"55","author":"Marques","year":"2011","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"10.1016\/j.beem.2018.09.004_bib64","doi-asserted-by":"crossref","first-page":"4641","DOI":"10.1210\/jc.2002-021404","article-title":"Normocalcemic primary hyperparathyroidism: evidence for a generalized target-tissue resistance to parathyroid hormone","volume":"88","author":"Maruani","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2018.09.004_bib65","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/MED.0000000000000198","article-title":"An overview of normocalcemic primary hyperparathyroidism","volume":"22","author":"Pawlowska","year":"2015","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.beem.2018.09.004_bib66","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.amjmed.2004.06.037","article-title":"Characterization of normocalcemic primary hyperparathyroidism","volume":"117","author":"Tordjman","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.beem.2018.09.004_bib67","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00774-015-0673-3","article-title":"Normocalcemic hyperparathyroidism is associated with complications similar to those of hypercalcemic hyperparathyroidism","volume":"34","author":"Tuna","year":"2016","journal-title":"J\u00a0Bone Miner Metabol"},{"key":"10.1016\/j.beem.2018.09.004_bib68","series-title":"The parathyroids","article-title":"Normocalcemic PHPT","author":"Cusano","year":"2015"},{"key":"10.1016\/j.beem.2018.09.004_bib69","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1365-2265.2008.03520.x","article-title":"Epidemiology of primary hyperparathyroidism in Tayside, Scotland, UK","volume":"71","author":"Yu","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.beem.2018.09.004_bib70","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1515\/cclm-2016-1183","article-title":"High-dose biotin therapy leading to false biochemical endocrine profiles: validation of a simple method to overcome biotin interference","volume":"55","author":"Piketty","year":"2017","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.beem.2018.09.004_bib71","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jocd.2011.03.004","article-title":"The 2011 IOM report on vitamin D and calcium requirements for north America: clinical implications for providers treating patients with low bone mineral density","volume":"14","author":"Rosen","year":"2011","journal-title":"J\u00a0Clin Densitom"},{"key":"10.1016\/j.beem.2018.09.004_bib72","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJM199803193381201","article-title":"Hypovitaminosis D in medical inpatients","volume":"338","author":"Thomas","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2018.09.004_bib73","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1210\/jc.2016-1513","article-title":"Forearm DXA increases the rate of patients with asymptomatic primary hyperparathyroidism meeting surgical criteria","volume":"101","author":"Castellano","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2018.09.004_bib74","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.4158\/EP14074.OR","article-title":"Silent renal stones in primary hyperparathyroidism: prevalence and clinical features","volume":"20","author":"Cassibba","year":"2014","journal-title":"Endocr Pract"},{"key":"10.1016\/j.beem.2018.09.004_bib75","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1002\/jbmr.3177","article-title":"Effect of surgery versus observation: skeletal 5-year outcomes in a randomized trial of patients with primary HPT (the SIPH study)","volume":"32","author":"Lundstam","year":"2017","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2018.09.004_bib76","doi-asserted-by":"crossref","first-page":"715","DOI":"10.7326\/M15-1232","article-title":"The relationship of parathyroidectomy and bisphosphonates with fracture risk in primary hyperparathyroidism: an observational study","volume":"164","author":"Yeh","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.beem.2018.09.004_bib77","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1007\/s00198-014-2689-2","article-title":"Individual site-specific bone mineral density gain in normocalcemic primary hyperparathyroidism","volume":"25","author":"Koumakis","year":"2014","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.beem.2018.09.004_bib78","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1210\/jc.2013-1518","article-title":"Bone mineral density evolution after successful parathyroidectomy in patients with normocalcemic primary hyperparathyroidism","volume":"98","author":"Koumakis","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2018.09.004_bib79","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1210\/jc.2014-1417","article-title":"Medical management of primary hyperparathyroidism: proceedings of the fourth international Workshop on the management of asymptomatic primary hyperparathyroidism","volume":"99","author":"Marcocci","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2018.09.004_bib80","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12020-016-1169-1","article-title":"Vitamin D and primary hyperparathyroidism: more insights into a complex relationship","volume":"55","author":"Walker","year":"2017","journal-title":"Endocrine"},{"key":"10.1016\/j.beem.2018.09.004_bib81","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s12020-016-0974-x","article-title":"Vitamin D status in primary hyperparathyroidism: effect of genetic background","volume":"55","author":"Battista","year":"2017","journal-title":"Endocrine"},{"key":"10.1016\/j.beem.2018.09.004_bib82","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1007\/s00198-015-3199-6","article-title":"Low vitamin D levels have become less common in primary hyperparathyroidism","volume":"26","author":"Walker","year":"2015","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.beem.2018.09.004_bib83","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.bone.2016.05.012","article-title":"Seasonal changes in serum calcium, PTH and vitamin D levels in patients with primary hyperparathyroidism","volume":"89","author":"Nevo-Shor","year":"2016","journal-title":"Bone"},{"key":"10.1016\/j.beem.2018.09.004_bib84","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1007\/s00198-017-3918-2","article-title":"Skeletal effects of vitamin D deficiency among patients with primary hyperparathyroidism","volume":"28","author":"Lee","year":"2017","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.beem.2018.09.004_bib85","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1007\/s00198-016-3637-0","article-title":"Effect of concomitant vitamin D deficiency or insufficiency on lumbar spine volumetric bone mineral density and trabecular bone score in primary hyperparathyroidism","volume":"27","author":"Walker","year":"2016","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.beem.2018.09.004_bib86","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1210\/jc.2015-4218","article-title":"Effect of low vitamin D on volumetric bone mineral density, bone microarchitecture, and stiffness in primary hyperparathyroidism","volume":"101","author":"Walker","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2018.09.004_bib87","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1210\/jc.2013-3978","article-title":"Vitamin D treatment in primary hyperparathyroidism: a randomized placebo controlled trial","volume":"99","author":"Rolighed","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2018.09.004_bib88","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1210\/jc.2002-020890","article-title":"Oral alendronate increases bone mineral density in postmenopausal women with primary hyperparathyroidism","volume":"88","author":"Chow","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2018.09.004_bib89","doi-asserted-by":"crossref","first-page":"705","DOI":"10.4158\/EP08178.ORR","article-title":"Alendronate therapy in men with primary hyperparathyroidism","volume":"15","author":"Khan","year":"2009","journal-title":"Endocr Pract"},{"key":"10.1016\/j.beem.2018.09.004_bib90","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1210\/jc.2003-030908","article-title":"Alendronate in primary hyperparathyroidism: a double-blind, randomized, placebo-controlled trial","volume":"89","author":"Khan","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2018.09.004_bib91","doi-asserted-by":"crossref","first-page":"4482","DOI":"10.1210\/jc.2001-010385","article-title":"Alendronate in the treatment of primary hyperparathyroid-related osteoporosis: a 2-year study","volume":"87","author":"Parker","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2018.09.004_bib92","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1359\/jbmr.2001.16.1.113","article-title":"Effects of oral alendronate in elderly patients with osteoporosis and mild primary hyperparathyroidism","volume":"16","author":"Rossini","year":"2001","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2018.09.004_bib93","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1007\/s00198-014-3000-2","article-title":"Effects of alendronate and vitamin D in patients with normocalcemic primary hyperparathyroidism","volume":"26","author":"Cesareo","year":"2015","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.beem.2018.09.004_bib94","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00774-013-0473-6","article-title":"Effect of parathyroidectomy versus risedronate on volumetric bone mineral density and bone geometry at the tibia in postmenopausal women with primary hyperparathyroidism","volume":"32","author":"Tournis","year":"2014","journal-title":"J\u00a0Bone Miner Metabol"},{"key":"10.1016\/j.beem.2018.09.004_bib95","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1210\/jc.2004-0842","article-title":"Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism","volume":"90","author":"Peacock","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2018.09.004_bib96","first-page":"655","article-title":"Cinacalcet efficacy in patients with moderately severe primary hyperparathyroidism according to the European Medicine Agency prescription labeling","volume":"35","author":"Cetani","year":"2012","journal-title":"J\u00a0Endocrinol Invest"},{"key":"10.1016\/j.beem.2018.09.004_bib97","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/2042018813482344","article-title":"Experience with cinacalcet in primary hyperparathyroidism: results after 1 year of treatment","volume":"4","author":"Luque-Fernandez","year":"2013","journal-title":"Therapeut Adv Endocrinol Metabol"},{"key":"10.1016\/j.beem.2018.09.004_bib98","doi-asserted-by":"crossref","first-page":"4860","DOI":"10.1210\/jc.2009-1472","article-title":"Cinacalcet treatment of primary hyperparathyroidism: biochemical and bone densitometric outcomes in a five-year study","volume":"94","author":"Peacock","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2018.09.004_bib99","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s12020-011-9459-0","article-title":"Cinacalcet hydrochloride in combination with alendronate normalizes hypercalcemia and improves bone mineral density in patients with primary hyperparathyroidism","volume":"39","author":"Faggiano","year":"2011","journal-title":"Endocrine"},{"key":"10.1016\/j.beem.2018.09.004_bib100","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1097\/SLA.0b013e31824c5252","article-title":"Calcimimetics versus parathyroidectomy for treatment of primary hyperparathyroidism: retrospective chart analysis of a prospective database","volume":"255","author":"Keutgen","year":"2012","journal-title":"Ann Surg"},{"key":"10.1016\/j.beem.2018.09.004_bib101","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1046\/j.0954-6820.2003.01237.x","article-title":"Parathyroid surgery is associated with a decreased risk of hip and upper arm fractures in primary hyperparathyroidism: a controlled cohort study","volume":"255","author":"Vestergaard","year":"2004","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.beem.2018.09.004_bib102","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s12020-016-1101-8","article-title":"Skeletal changes after restoration of the euparathyroid state in patients with hypoparathyroidism and primary hyperparathyroidism","volume":"55","author":"Cipriani","year":"2017","journal-title":"Endocrine"},{"key":"10.1016\/j.beem.2018.09.004_bib103","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1210\/jc.2017-01932","article-title":"Skeletal microstructure and estimated bone strength improve following parathyroidectomy in primary hyperparathyroidism","volume":"103","author":"Cusano","year":"2018","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2018.09.004_bib104","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/jbmr.1540","article-title":"Parathyroidectomy improves bone geometry and microarchitecture in female patients with primary hyperparathyroidism: a one-year prospective controlled study using high-resolution peripheral quantitative computed tomography","volume":"27","author":"Hansen","year":"2012","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2018.09.004_bib105","doi-asserted-by":"crossref","first-page":"R39","DOI":"10.1530\/EJE-16-0430","article-title":"Mechanisms in endocrinology: kidney involvement in patients with primary hyperparathyroidism: an update on clinical and molecular aspects","volume":"176","author":"Verdelli","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2018.09.004_bib106","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1007\/s00198-016-3715-3","article-title":"Comparative efficacy of parathyroidectomy and active surveillance in patients with mild primary hyperparathyroidism: a systematic review and meta-analysis","volume":"27","author":"Singh Ospina","year":"2016","journal-title":"Osteoporos Int"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X18301040?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X18301040?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:54:08Z","timestamp":1761497648000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X18301040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":106,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S1521690X18301040"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2018.09.004","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary hyperparathyroidism","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2018.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}